Three pillars of post-pandemic launch excellenceIQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity Share XThree pillars of post-pandemic launch excellencehttps://pharmaphorum.com/views-and-analysis/three-pillars-of-post-pandemic-launch-excellence/
The new global digital health paradigm in life sciencesDigital transformation has long been a priority for all life science companies and it has been made even Share XThe new global digital health paradigm in life scienceshttps://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
Achieving launch excellence in orphan medicinesNew rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking Share XAchieving launch excellence in orphan medicineshttps://pharmaphorum.com/market-access-2/achieving-launch-excellence-in-orphan-medicines/
Launch excellence in a disrupted world – challenges & opportunitiesOverview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care Share XLaunch excellence in a disrupted world – challenges & opportunitieshttps://pharmaphorum.com/market-access-2/launch-excellence-in-a-disrupted-world-challenges-opportunities/
